Literature DB >> 14647499

Erythropoietin may impair, not improve, cancer survival.

Vicki Brower.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14647499     DOI： 10.1038/nm1203-1439

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  2 in total

1.  Survival and erythropoietin receptor protein in tumours from patients randomly treated with rhEPO for palliative care.

Authors:  Christina Lönnroth; Marie Svensson; Wenhua Wang; Ulla Körner; Peter Daneryd; Ola Nilsson; Kent Lundholm
Journal:  Med Oncol       Date:  2007-09-11       Impact factor: 3.064

Review 2.  Science review: recombinant human erythropoietin in critical illness: a role beyond anemia?

Authors:  Thomas Coleman; Michael Brines
Journal:  Crit Care       Date:  2004-06-16       Impact factor: 9.097
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.